Secondary Logo

Journal Logo

You can read the full text of this article if you:

Institutional members access full text with Ovid®

Research Papers

Determination of the dose of agomelatine, a melatoninergic agonist and selective 5-HT2C antagonist, in the treatment of major depressive disorder: a placebo-controlled dose range study

Lôo, H.a; Hale, A.b; D'haenen, H.c

Author Information
International Clinical Psychopharmacology: September 2002 - Volume 17 - Issue 5 - p 239-247
  • Buy

Abstract

© 2002 Lippincott Williams & Wilkins, Inc.